Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
To determine safety and effectiveness of low-dose therapeutic AEGR-733 +/- atorvastatin,
ezetimibe or fenofibrate (compared to placebo) on liver fat accumulation measured by Magnetic
Resonance Spectroscopy